{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T19:05:56Z","timestamp":1789239956739,"version":"build-2803163510"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      Bacterial etiologies of acute otitis media (AOM) have shifted from the introduction of pneumococcal conjugate vaccines (PCVs), antibiotic selection and competition among species. We characterized\n                      <jats:italic toggle=\"yes\">Streptococcus pneumoniae<\/jats:italic>\n                      (\n                      <jats:italic toggle=\"yes\">Spn<\/jats:italic>\n                      ),\n                      <jats:italic toggle=\"yes\">Haemophilus influenzae<\/jats:italic>\n                      (\n                      <jats:italic toggle=\"yes\">Hflu<\/jats:italic>\n                      ) and\n                      <jats:italic toggle=\"yes\">Moraxella catarrhalis<\/jats:italic>\n                      (\n                      <jats:italic toggle=\"yes\">Mcat<\/jats:italic>\n                      ) in the nasopharynx during well-child healthy visits and at the onset of AOM, and in middle ear fluid (MEF) of children with AOM to assess anticipated effects of higher-valency PCVs (PCV15 and PCV20).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      From September 2021 to September 2023, we conducted a prospective longitudinal cohort study of PCV13 immunized children 6\u201336 months old. MEF was collected via tympanocentesis. Serotyping and antibiotic susceptibility testing were performed on\n                      <jats:italic toggle=\"yes\">Spn<\/jats:italic>\n                      ,\n                      <jats:italic toggle=\"yes\">Hflu<\/jats:italic>\n                      and\n                      <jats:italic toggle=\"yes\">Mcat<\/jats:italic>\n                      isolates.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      We obtained 825 nasopharyngeal and 216 MEF samples from 301 children. The order of frequency of nasopharyngeal colonization was\n                      <jats:italic toggle=\"yes\">Mcat<\/jats:italic>\n                      ,\n                      <jats:italic toggle=\"yes\">Spn<\/jats:italic>\n                      and\n                      <jats:italic toggle=\"yes\">Hflu<\/jats:italic>\n                      ;\n                      <jats:italic toggle=\"yes\">Hflu<\/jats:italic>\n                      was the predominant otopathogen in MEF. Among\n                      <jats:italic toggle=\"yes\">Spn<\/jats:italic>\n                      isolates, non-PCV15, non-PCV20 serotypes predominated in the nasopharynx and in MEF; the most frequent serotype was 35B. Among MEF samples, 30% of\n                      <jats:italic toggle=\"yes\">Spn<\/jats:italic>\n                      isolates were amoxicillin nonsusceptible; 23% of\n                      <jats:italic toggle=\"yes\">Hflu<\/jats:italic>\n                      isolates and 100% of\n                      <jats:italic toggle=\"yes\">Mcat<\/jats:italic>\n                      isolates were \u03b2-lactamase-producing.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>\n                      The majority of\n                      <jats:italic toggle=\"yes\">Spn<\/jats:italic>\n                      isolates among young children were non-PCV15, non-PCV20 serotypes, especially serotype 35B; therefore, the impact of higher-valency PCVs in reducing pneumococcal colonization or AOM is expected to be limited.\n                      <jats:italic toggle=\"yes\">Hflu<\/jats:italic>\n                      continues to be the most frequent AOM pathogen. Antibiotic susceptibility data suggest a high dose of amoxicillin\/clavulanate or alternative drugs that are effective against contemporary mix of otopathogens could be considered for optimal empiric selection to provide the best efficacy.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000004413","type":"journal-article","created":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T15:06:57Z","timestamp":1717600017000},"page":"1004-1010","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":14,"title":["Anticipated Effects of Higher-valency Pneumococcal Conjugate Vaccines on Colonization and Acute Otitis Media"],"prefix":"10.1097","volume":"43","author":[{"given":"Ravinder","family":"Kaur","sequence":"first","affiliation":[{"name":"From the Center for Infectious Diseases and Immunology, Rochester General Hospital Research Institute, Rochester, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Schulz","sequence":"additional","affiliation":[{"name":"From the Center for Infectious Diseases and Immunology, Rochester General Hospital Research Institute, Rochester, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Sherman","sequence":"additional","affiliation":[{"name":"From the Center for Infectious Diseases and Immunology, Rochester General Hospital Research Institute, Rochester, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Andrejko","sequence":"additional","affiliation":[{"name":"Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miwako","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8276-3938","authenticated-orcid":false,"given":"Michael","family":"Pichichero","sequence":"additional","affiliation":[{"name":"From the Center for Infectious Diseases and Immunology, Rochester General Hospital Research Institute, Rochester, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,6,5]]},"reference":[{"key":"R1-20250614","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S1473-3099(04)00938-7","article-title":"Streptococcus pneumoniae colonisation: the key to pneumococcal disease.","volume":"4","author":"Bogaert","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"R2-20250614","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM200102083440602","article-title":"Efficacy of a pneumococcal conjugate vaccine against acute otitis media.","volume":"344","author":"Eskola","year":"2001","journal-title":"N Engl J Med"},{"key":"R3-20250614","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1097\/01.inf.0000143645.58215.f0","article-title":"Seven valent pneumococcal conjugate vaccine immunization in two Boston communities: changes in serotypes and antimicrobial susceptibility among Streptococcus pneumoniae isolates.","volume":"23","author":"Pelton","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"R4-20250614","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S2352-4642(18)30168-8","article-title":"Effectiveness of 13-valent pneumococcal conjugate vaccination for protection against acute otitis media caused by Streptococcus pneumoniae in healthy young children: a prospective observational study.","volume":"2","author":"Pichichero","year":"2018","journal-title":"Lancet Child Adolesc Health"},{"key":"R5-20250614","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1086\/595857","article-title":"Changing epidemiology of antimicrobial-resistant Streptococcus pneumoniae in the United States, 2004-2005.","volume":"48","author":"Richter","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R6-20250614","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/cid\/ciaa157","article-title":"Rising pneumococcal antibiotic resistance in the post-13-valent pneumococcal conjugate vaccine era in pediatric isolates from a primary care setting.","volume":"72","author":"Kaur","year":"2021","journal-title":"Clin Infect Dis"},{"key":"R7-20250614","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/01.inf.0000253059.84602.c3","article-title":"Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States.","volume":"26","author":"Farrell","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"R8-20250614","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/INF.0b013e31824ba6f7","article-title":"When co-colonizing the nasopharynx haemophilus influenzae predominates over Streptococcus pneumoniae except serotype 19A strains to cause acute otitis media.","volume":"31","author":"Xu","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"R9-20250614","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S2213-2600(16)00052-7","article-title":"Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease in children in the USA: a matched case-control study.","volume":"4","author":"Moore","year":"2016","journal-title":"Lancet Respir Med"},{"key":"R10-20250614","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.jval.2021.12.012","article-title":"Effectiveness of pneumococcal vaccines on otitis media in children: a systematic review.","volume":"25","author":"Marra","year":"2022","journal-title":"Value Health"},{"key":"R11-20250614","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0140-6736(06)69637-2","article-title":"Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study.","volume":"368","author":"Whitney","year":"2006","journal-title":"Lancet"},{"key":"R12-20250614","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.","volume":"348","author":"Whitney","year":"2003","journal-title":"N Engl J Med"},{"key":"R13-20250614","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/jac\/dkp210","article-title":"Emergence of a multidrug-resistant clone (ST320) among invasive serotype 19A pneumococci in Spain.","volume":"64","author":"Ardanuy","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"R14-20250614","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1001\/jama.298.15.1772","article-title":"Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children.","volume":"298","author":"Pichichero","year":"2007","journal-title":"JAMA"},{"key":"R15-20250614","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10096-021-04324-0","article-title":"Dynamic changes in otopathogens colonizing the nasopharynx and causing acute otitis media in children after 13-valent (PCV13) pneumococcal conjugate vaccination during 2015-2019.","volume":"41","author":"Kaur","year":"2022","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R16-20250614","doi-asserted-by":"crossref","first-page":"e20170101","DOI":"10.1542\/peds.2017-0181","article-title":"Epidemiology of acute otitis media in the postpneumococcal conjugate vaccine era.","volume":"140","author":"Kaur","year":"2017","journal-title":"Pediatrics"},{"key":"R17-20250614","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/INF.0000000000001206","article-title":"Emerging Streptococcus pneumoniae strains colonizing the nasopharynx in children after 13-valent pneumococcal conjugate vaccination in comparison to the 7-valent era, 2006-2015.","volume":"35","author":"Kaur","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"R18-20250614","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/INF.0b013e318275614b","article-title":"Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine.","volume":"32","author":"Kaplan","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"R19-20250614","doi-asserted-by":"crossref","first-page":"e493","DOI":"10.1542\/peds.2009-3027","article-title":"Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in infants and toddlers.","volume":"126","author":"Yeh","year":"2010","journal-title":"Pediatrics"},{"key":"R20-20250614","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1097\/INF.0b013e318199f8ef","article-title":"Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine.","volume":"28","author":"Vesikari","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R21-20250614","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1542\/peds.2009-1405","article-title":"Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine.","volume":"125","author":"Bryant","year":"2010","journal-title":"Pediatrics"},{"key":"R22-20250614","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1016\/j.vaccine.2022.03.048","article-title":"Vaccine effectiveness of the 7-valent and 13-valent pneumococcal conjugate vaccines in Canada: an IMPACT study.","volume":"40","author":"Ricketson","year":"2022","journal-title":"Vaccine"},{"key":"R23-20250614","doi-asserted-by":"crossref","first-page":"e0209048","DOI":"10.1371\/journal.pone.0209048","article-title":"Changes in the serotype distribution of Streptococcus pneumoniae causing otitis media after PCV13 introduction in Spain.","volume":"13","author":"Morales","year":"2018","journal-title":"PLoS One"},{"key":"R24-20250614","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.vaccine.2022.12.054","article-title":"A phase 3, multicenter, randomized, double-blind, active-comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of a 4-dose regimen of V114, a 15-valent pneumococcal conjugate vaccine, in healthy infants (PNEU-PED).","volume":"41","author":"Lupinacci","year":"2023","journal-title":"Vaccine"},{"key":"R26-20250614","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1097\/INF.0000000000003277","article-title":"Safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine in healthy infants in the United States.","volume":"40","author":"Senders","year":"2021","journal-title":"Pediatr Infect Dis J"},{"key":"R27-20250614","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.15585\/mmwr.mm7239a5","article-title":"ACIP updates: recommendations for use of 20-valent pneumococcal conjugate vaccine in children - United States, 2023.","volume":"72","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R28-20250614","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.15585\/mmwr.mm7137a3","article-title":"Use of 15-valent pneumococcal conjugate vaccine among U.S. children: updated recommendations of the advisory committee on immunization practices - United States, 2022.","volume":"71","author":"Kobayashi","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R29-20250614","doi-asserted-by":"crossref","first-page":"109","DOI":"10.15585\/mmwr.mm7104a1","article-title":"Use of 15-valent pneumococcal conjugate vaccine and 20-valent pneumococcal conjugate vaccine among U.S. adults: updated recommendations of the advisory committee on immunization practices - United States, 2022.","volume":"71","author":"Kobayashi","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R30-20250614","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/INF.0b013e31828d9acc","article-title":"Acute otitis media otopathogens during 2008 to 2010 in Rochester, New York.","volume":"32","author":"Casey","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"R31-20250614","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/INF.0b013e3181d9e639","article-title":"Simultaneous assay for four bacterial species including Alloiococcus otitidis using multiplex-PCR in children with culture negative acute otitis media.","volume":"29","author":"Kaur","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"R32-20250614","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1128\/JCM.39.9.3129-3134.2001","article-title":"Quantitative detection of Streptococcus pneumoniae in nasopharyngeal secretions by real-time PCR.","volume":"39","author":"Greiner","year":"2001","journal-title":"J Clin Microbiol"},{"key":"R33-20250614","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1097\/INF.0000000000003171","article-title":"Haemophilus influenzae prevalence, proportion of capsulated strains and antibiotic susceptibility during colonization and acute otitis media in children, 2019-2020.","volume":"40","author":"Fuji","year":"2021","journal-title":"Pediatr Infect Dis J"},{"key":"R34-20250614","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/01.inf.0000136871.51792.19","article-title":"Changes in frequency and pathogens causing acute otitis media in 1995-2003.","volume":"23","author":"Casey","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"R35-20250614","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/INF.0b013e3181c1bc48","article-title":"New patterns in the otopathogens causing acute otitis media six to eight years after introduction of pneumococcal conjugate vaccine.","volume":"29","author":"Casey","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"R36-20250614","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1017\/S0950268813003178","article-title":"Five-year prospective study of paediatric acute otitis media in Rochester, NY: modelling analysis of the risk of pneumococcal colonization in the nasopharynx and infection.","volume":"142","author":"Friedel","year":"2014","journal-title":"Epidemiol Infect"},{"key":"R37-20250614","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/INF.0000000000001216","article-title":"Ten-year study of acute otitis media in Rochester, NY.","volume":"35","author":"Pichichero","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"R38-20250614","doi-asserted-by":"crossref","first-page":"744742","DOI":"10.3389\/fcimb.2021.744742","article-title":"Transition of serotype 35B pneumococci from commensal to prevalent virulent strain in children.","volume":"11","author":"Fuji","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"R39-20250614","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiae184","article-title":"Pneumococci isolated from children in community-based practice differ from isolates identified by population and laboratory-based invasive disease surveillance [published online ahead of print].","author":"Kaur","year":"2024","journal-title":"J Infect Dis"},{"key":"R40-20250614","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1080\/14760584.2023.2162506","article-title":"Acute otitis media pneumococcal disease burden and nasopharyngeal colonization in children due to serotypes included and not included in current and new pneumococcal conjugate vaccines.","volume":"22","author":"Pichichero","year":"2023","journal-title":"Expert Rev Vaccines"},{"key":"R41-20250614","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1001\/jamapediatrics.2019.5509","article-title":"Trends in pediatric primary care visits among commercially insured US children, 2008-2016.","volume":"174","author":"Ray","year":"2020","journal-title":"JAMA Pediatr"},{"key":"R42-20250614","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1001\/jama.2016.4151","article-title":"Prevalence of Inappropriate Antibiotic Prescriptions Among US Ambulatory Care Visits, 2010-2011.","volume":"315","author":"Fleming-Dutra","year":"2016","journal-title":"JAMA"},{"key":"R43-20250614","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/ash.2021.230","article-title":"Changes in outpatient antibiotic prescribing for acute respiratory illnesses, 2011 to 2018.","volume":"1","author":"King","year":"2021","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"key":"R44-20250614","article-title":"Pediatric outpatient visits and antibiotic use attributable to higher valency pneumococcal conjugate vaccine serotypes.","author":"King","year":"2023","journal-title":"medRxiv"},{"key":"R45-20250614","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/lary.24190","article-title":"Incremental health care utilization and costs for acute otitis media in children.","volume":"124","author":"Ahmed","year":"2014","journal-title":"Laryngoscope"},{"key":"R46-20250614","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1177\/0009922814533592","article-title":"Payment analysis of two diagnosis and management approaches of acute otitis media.","volume":"53","author":"Casey","year":"2014","journal-title":"Clin Pediatr (Phila)"},{"key":"R47-20250614","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1080\/14760584.2017.1393335","article-title":"Pneumococcal whole-cell and protein-based vaccines: changing the paradigm.","volume":"16","author":"Pichichero","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"R48-20250614","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/01.inf.0000136868.91756.80","article-title":"Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media.","volume":"23","author":"Block","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"R49-20250614","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2165\/00148581-200911040-00003","article-title":"Variations in amoxicillin pharmacokinetic\/pharmacodynamic parameters may explain treatment failures in acute otitis media.","volume":"11","author":"Pichichero","year":"2009","journal-title":"Paediatr Drugs"},{"key":"R50-20250614","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2165\/0148581-200810060-00006","article-title":"Probability of achieving requisite pharmacodynamic exposure for oral beta-lactam regimens against Haemophilus influenzae in children.","volume":"10","author":"Pichichero","year":"2008","journal-title":"Paediatr Drugs"},{"key":"R51-20250614","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.2165\/11590320-000000000-00000","article-title":"Comparison of amoxicillin\/clavulanic acid high dose with cefdinir in the treatment of acute otitis media.","volume":"72","author":"Casey","year":"2012","journal-title":"Drugs"},{"key":"R52-20250614","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1177\/0009922808319966","article-title":"Pathogens causing recurrent and difficult-to-treat acute otitis media, 2003-2006.","volume":"47","author":"Pichichero","year":"2008","journal-title":"Clin Pediatr (Phila)"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004413","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T19:05:48Z","timestamp":1749927948000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,5]]},"references-count":51,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000004413","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,5]]}}}